What question did this study set out to answer?

The study aims to evaluate TcGAPDH as a vaccine candidate against Chagas disease using bioinformatics.

February 19, 2026Acta ParasitologicaOpen Access

In Silico Design and Evaluation of TcGAPDH as a Vaccine Against Chagas Disease: A Reverse Vaccinology Approach

View Full Paper

Ask AI

Bookmark

Authors

Bioinformatics analysis identifies TcGAPDH as a viable vaccine candidate against Chagas disease, suggesting further development.

The study aims to evaluate TcGAPDH as a vaccine candidate against Chagas disease using bioinformatics.
Utilized bioinformatics to analyze TcGAPDH's physicochemical and immunogenic properties.
Predicted epitopes for B and T lymphocytes.
Assessed immune response potential focusing on Th1-type response factors.
Conducted molecular docking and dynamics simulation with TLR2/TLR4 receptors.
TcGAPDH demonstrates the capacity to induce a Th1-type immune response.
Molecular docking shows strong, consistent interactions with TLR2 and TLR4 over 300 ns.

Nava-Cuamatzi et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark